167 related articles for article (PubMed ID: 33860360)
21. ASO Author Reflections: Treatment Strategies for Locally Advanced Borderline Resectable Esophageal Squamous Cell Carcinoma.
Hong Y
Ann Surg Oncol; 2024 Feb; 31(2):896. PubMed ID: 37962739
[No Abstract] [Full Text] [Related]
22. ASO Author Reflections: Can Circulating Tumor DNA Guide Individualized Treatment for Patients with Esophageal Squamous Cell Carcinoma?
Morimoto Y; Matsuda S; Kawakubo H; Nakamura K; Kobayashi R; Hisaoka K; Okui J; Takeuchi M; Aimono E; Fukuda K; Nakamura R; Saya H; Nishihara H; Kitagawa Y
Ann Surg Oncol; 2023 Jun; 30(6):3757-3758. PubMed ID: 36807023
[No Abstract] [Full Text] [Related]
23. ASO Author Reflections: Functional Analysis and Clinical Significance of Chloride Channel 2 Expression in Esophageal Squamous Cell Carcinoma.
Mitsuda M; Shiozaki A; Otsuji E
Ann Surg Oncol; 2021 Sep; 28(9):5398-5399. PubMed ID: 33590362
[No Abstract] [Full Text] [Related]
24. ASO Author Reflections: Esophagectomy or Chemoradiotherapy, That is the Question: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma.
Kanie Y; Okamura A; Asari T; Ishiyama A; Yoshio T; Tsuchida T; Chin K; Watanabe M
Ann Surg Oncol; 2021 Dec; 28(13):8436-8437. PubMed ID: 34115253
[No Abstract] [Full Text] [Related]
25. ASO Author Reflections: KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma.
Nakamura S; Kanda M; Kodera Y
Ann Surg Oncol; 2020 Jul; 27(7):2569-2570. PubMed ID: 32166595
[No Abstract] [Full Text] [Related]
26. ASO Author Reflections: Optimizing Proximal Esophageal Squamous Cell Carcinoma Treatment.
Patel DC; Berry MF
Ann Surg Oncol; 2023 Feb; 30(2):828-829. PubMed ID: 36258059
[No Abstract] [Full Text] [Related]
27. ASO Author Reflections: Safety of Elective Esophagectomy Performed on Weekend for Patients with Esophageal Carcinoma.
Yang TY; Chao YK
Ann Surg Oncol; 2023 Jun; 30(6):3799. PubMed ID: 36905439
[No Abstract] [Full Text] [Related]
28. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
[TBL] [Abstract][Full Text] [Related]
29. ASO Author Reflections: Expression and Role of CFTR in Human Esophageal Squamous Cell Carcinoma.
Matsumoto Y; Shiozaki A; Otsuji E
Ann Surg Oncol; 2021 Oct; 28(11):6437-6438. PubMed ID: 33710507
[No Abstract] [Full Text] [Related]
30. ASO Author Reflections: Association Between Preoperative Coagulation Status and Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma After Neoadjuvant Treatment.
Sugiyama F; Kanda M; Kodera Y
Ann Surg Oncol; 2024 May; 31(5):3473-3474. PubMed ID: 38261127
[No Abstract] [Full Text] [Related]
31. ASO Author Reflections: Prognostic Role of a Coagulation Index for Patients with Esophageal Squamous Cell Cancer.
Wang Q; Cao B; Mi K
Ann Surg Oncol; 2021 Dec; 28(13):8462-8463. PubMed ID: 34106387
[No Abstract] [Full Text] [Related]
32. ASO Author Reflections: Prediction of the Therapeutic Efficacy in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Okamura A; Matsuda S; Kawakubo H; Mine S; Takeuchi H; Kitagawa Y; Watanabe M
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):795-796. PubMed ID: 32591950
[No Abstract] [Full Text] [Related]
33. ASO Author Reflections: The Lymph Node Ratio is an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma After Minimally Invasive Esophagectomy.
Kitamura Y; Oshikiri T
Ann Surg Oncol; 2021 Aug; 28(8):4529. PubMed ID: 33399999
[No Abstract] [Full Text] [Related]
34. Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer.
Mei X; Zhu X; Zuo L; Wu H; Guo M; Liu C
Int J Biol Markers; 2019 Jun; 34(2):200-204. PubMed ID: 31088185
[TBL] [Abstract][Full Text] [Related]
35. ASO Author Reflections: Clinical Impact of Metastatic Lymph Node Size on Therapeutic Effect and Prognosis in Patients with Esophageal Squamous Cell Carcinoma Who Underwent Preoperative Chemotherapy Followed by Esophagectomy.
Sugimura K; Miyata H; Kanemura T; Takeoka T; Sugase T; Yamamoto M; Shinnno N; Hara H; Omori T; Motoori M; Ohue M; Yano M
Ann Surg Oncol; 2023 Jul; 30(7):4203-4204. PubMed ID: 37029864
[No Abstract] [Full Text] [Related]
36. ASO Author Reflections: Serine Protease 27 is a Novel Prognostic Indicator for Esophageal Squamous Cell Carcinoma with Preoperative Treatment.
Kataoka A; Yamada K; Kawamura YI
Ann Surg Oncol; 2021 Sep; 28(9):5382-5383. PubMed ID: 33454876
[No Abstract] [Full Text] [Related]
37. ASO Author Reflections: Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma.
Chan WL
Ann Surg Oncol; 2023 Feb; 30(2):871-872. PubMed ID: 36380255
[No Abstract] [Full Text] [Related]
38. ASO Author Reflections: A Novel, Sensitive, and Effective Index in Predicting Therapeutic Response of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma.
Feng J; Wang L; Yang X; Chen Q; Cheng X
Ann Surg Oncol; 2024 Jan; 31(1):241-242. PubMed ID: 37838649
[No Abstract] [Full Text] [Related]
39. ASO Author Reflections: Prognostic Significance of Kallikrein-Related Peptidase 13 Induction After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
Shimomura A; Yamada K; Kawamura YI
Ann Surg Oncol; 2024 Jan; 31(1):243-244. PubMed ID: 37851200
[No Abstract] [Full Text] [Related]
40. Clinical Significance of Pretherapeutic Serum Squamous Cell Carcinoma Antigen Level in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Okamura A; Matsuda S; Mayanagi S; Kanamori J; Imamura Y; Irino T; Kawakubo H; Mine S; Takeuchi H; Kitagawa Y; Watanabe M
Ann Surg Oncol; 2021 Feb; 28(2):1209-1216. PubMed ID: 32524457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
